● Recruiting

Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers

Condition: Salivary Gland Cancer · Adenoid Cystic Carcinoma of the Salivary Gland · Squamous Cell Carcinoma of Head and Neck · Sponsor: Brigham and Women's Hospital

PhaseEARLY_Phase 1

Planned participants30

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This research study is studying the effect of different drugs as possible treatments for salivary and other head and neck cancers/ The name of the study intervention involved in this study is: \-- implantable microdevice

This description comes directly from the study's public registry record.

Talk to the study team

Glenn J. Hanna, M.D. · (617) 632-3090 · glenn_hanna@dfci.harvard.edu

Oliver Jonas, Ph.D. · OJONAS@BWH.HARVARD.EDU

Always discuss trial participation with your own doctor first.

Locations (2)

Brigham and Women's Hospital	Boston, Massachusetts, United States	Recruiting
Dana Farber Cancer Institute	Boston, Massachusetts, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05553782